RNA-Binding Proteins Regulate CD8 + T Cell Biology: Mechanisms and Therapeutic Opportunities
Expert Reviews in Molecular Medicine · 2026
DOI: 10.1017/erm.2026.10075 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Expert Reviews in Molecular Medicine, 2026. Verfasst von Ashwin B R Kumar. Beteiligte Einrichtung: Biophysics, Structural, and Computational Biology Graduate Program, Department of Biochemistry and Biophysics, University of Rochester Medical Center…. Hauptthemen laut MEDLINE: CD8-Positive T-Lymphocytes, RNA-Binding Proteins. Die Arbeit nennt 87 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
Immune-related diseases contribute substantially to global morbidity and mortality. CD8 + T cells play a critical role in adaptive immunity by eliminating virus-infected and malignant cells. The biology of CD8 + T cells is governed by tightly regulated gene expression programs, and disruption of these programs can lead to diverse immunopathologies and malignancies. This article evaluates our current understanding of post-transcriptional and translational regulation of gene expression in CD8 + T cells by RNA-binding proteins.
Methods
Relevant and up-to-date literature was critically analysed to gain mechanistic insights into the roles of RNA-binding proteins in CD8 + T cell biology and to identify key knowledge gaps and future directions, with particular emphasis on therapeutic implications.
Results
RNA-binding proteins regulate diverse aspects of CD8 + T cell biology, including differentiation, cytokine production, stress adaptation and proliferation. Recent studies further reveal how dysregulated expression and function of RNA-binding proteins contribute to hyperinflammation and haematological malignancies.
Conclusions
RNA-binding proteins are emerging as key post-transcriptional and translational checkpoint regulators of CD8 + T cell biology and represent promising therapeutic targets for immune-related diseases; however, substantial mechanistic and disease-specific studies, as well as rigorous translational validation, are required before RNA-binding protein-targeted therapeutic strategies can be safely and effectively advanced into clinical practice.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Biophysics, Structural, and Computational Biology Graduate Program, Department of Biochemistry and Biophysics, University of Rochester Medical Center, Rochester, New York, USA.
- Genome Informatics Team, Genotypic Technology Pvt Ltd, Bengaluru, Karnataka, India.
ORCID-Profile: Ashwin B R Kumar
Zitieren
APA
Kumar, A. B. R. (2026). RNA-Binding Proteins Regulate CD8 + T Cell Biology: Mechanisms and Therapeutic Opportunities. Expert Reviews in Molecular Medicine. https://doi.org/10.1017/erm.2026.10075
Vancouver
Kumar ABR. RNA-Binding Proteins Regulate CD8 + T Cell Biology: Mechanisms and Therapeutic Opportunities. Expert Reviews in Molecular Medicine. 2026. doi:10.1017/erm.2026.10075
BibTeX
@article{Kumar2026,
author = {Kumar, Ashwin B R},
title = {RNA-Binding Proteins Regulate CD8 + T Cell Biology: Mechanisms and Therapeutic Opportunities},
journal = {Expert Reviews in Molecular Medicine},
year = {2026},
doi = {10.1017/erm.2026.10075}
}
EUVIMED